Publisher: Bentham Science Publishers
E-ISSN: 1875-676x|5|2|120-126
ISSN: 1573-4129
Source: Current Pharmaceutical Analysis, Vol.5, Iss.2, 2009-05, pp. : 120-126
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Natalizumab in multiple sclerosis: proceed with caution?
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. :
Skip ibutilide therapy, proceed straight to DC cardioversion
Inpharma, Vol. 1, Iss. 1231, 2000-01 ,pp. :